Investor Relations

SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and

... More »

pdf SciClone Corporate Presentation June, 2015.

Recent Releases

Jul 23, 2015
SciClone Pharmaceuticals To Report Financial Results For The Second Quarter 2015 On August 10th

May 27, 2015
SciClone Pharmaceuticals and Theravance Biopharma Enter Into Development and Commercialization Agreement for VIBATIV(R) (Telavancin) in China

View all releases »

Events & Presentations

Aug 10, 2015 at 4:30 PM ET
Q2 2015 SciClone Pharmaceuticals, Inc. Earnings

Jun 3, 2015 at 10:00 AM ET
Jefferies 2015 Global Healthcare Conference

View all events & presentations »

Stock Chart
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote
SciClone Pharmaceuticals, Inc.
Price: 9.11
Change: - 0.10
Day High: 9.49
Day Low: 9.03
Volume: 319,300
Delayed at least 20 minutes.
Provided by eSignal.